Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
10.92
+0.79 (7.80%)
At close: Jul 16, 2025, 4:00 PM
10.98
+0.06 (0.55%)
After-hours: Jul 16, 2025, 6:04 PM EDT
Tyra Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts that cover Tyra Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $30.86, which forecasts a 182.6% increase in the stock price over the next year. The lowest target is $28 and the highest is $33.
Price Target: $30.86 (+182.6%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tyra Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 3 | 3 | 3 | 4 | 4 | 4 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +174.73% | Jul 1, 2025 |
Piper Sandler | Piper Sandler | Buy Initiates $33 | Buy | Initiates | $33 | +202.20% | May 21, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +174.73% | Mar 31, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +174.73% | Feb 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +174.73% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
n/a
from 228.70M
Revenue Next Year
n/a
EPS This Year
-2.16
from -1.51
EPS Next Year
-2.43
from -2.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 20.5M | ||
Avg | n/a | n/a | 9.6M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -2.00 | -1.70 | -2.38 | ||
Avg | -2.16 | -2.43 | -2.63 | ||
Low | -2.22 | -2.65 | -2.84 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.